Long Hill
Sector: Hospital • Location: China
Source: International Finance Corporation (IFC)
Long Hill Capital Venture Partners 1 LP (“Long Hill” or “the Fund”) is a venture capital fund which focuses on health and consumption services investments in China. The Fund aims to provide capital to early stage services-oriented companies. IFC would be investing in the Fund with established institutional investors.
- Status
- Prospective
- Sector
- Hospital, Education
- Location
- China
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Long Hill
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Long Hill Capital Venture Partners 1 LP (“Long Hill” or “the Fund”) is a venture capital fund which focuses on health and consumption services investments in China. The Fund aims to provide capital to early stage services-oriented companies. IFC would be investing in the Fund with established institutional investors. |
Original sector | P-BB - Venture Capital Fund |
Budget |
Location
Country | China |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Hospital, Education |
Article published date | 2026-04-26 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in China
- Integrated Waste Treatment Project in Xinjiang Uygur Autonomous Region
- Zoetis’ Animal Vaccine Research and Manufacturing Complex, Suzhou
- Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China
- WuXi Biologics’ Biologics Manufacturing Centre, Shijiazhuang, China
- Pfizer Global Biotechnology Centre, Hangzhou, China
- Boehringer Ingelheim Biopharmaceuticals Project, Shanghai
- Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China
- Shanghai CP Guojan API Production Suite, Shanghai
